Skip to main content
Clinical Trials/ISRCTN32082979
ISRCTN32082979
Recruiting
Not Applicable

Treatment of restriction in fetal growth with L-arginine: randomized clinical trial, double-blind, controlled with placebo

Fundación para Formación e Investigación Sanitaria0 sites130 target enrollmentMarch 12, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intrauterine growth restriction (IUGR)
Sponsor
Fundación para Formación e Investigación Sanitaria
Enrollment
130
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 12, 2018
End Date
December 1, 2020
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Fundación para Formación e Investigación Sanitaria

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \=18 years
  • 2\. Single pregnancy
  • 3\. Ultrasonographic diagnosis of IUGR: estimated fetal weight lower than the 10th percentile for gestational age according to local or national reference values, independently of the results of the Doppler parameters of the umbilical, middle cerebral and/or uterine arteries
  • 4\. Live fetuses at 11 and 13 at weeks gestation
  • 6\. Gestational age between 24 and 32 weeks
  • 7\. No indication of imminent or planned birth
  • 8\. Availability to participate in the study and sign the consent

Exclusion Criteria

  • 1\. Women with medical complications such as preeclampsia, chronic hypertension, kidney disease, diabetes mellitus, liver dysfunction, autoimmune disease or other significant medical complications
  • 2\. Women with a history of major mental disorders (schizophrenia, manic\-depressive illness)
  • 3\. Women in labor or with imminent or planned delivery
  • 4\. Fetal malformation
  • 5\. Acute fetal distress
  • 6\. IUGR associated with infectious disease
  • 7\. Multiple pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials